Rank
[2009 Rank]
Company & Headquarters [website] 2009Rx Sales (Billions
of USD) [change from 2008]
2009 R&D spend
(Millions of USD)
2009 Top-Selling Drugs
[Billions of USD]
1 [1]
Pfi zer
New York, New York [pfi zer.com] $45.4 [2.7%] $7845
Lipitor [11.4]
Lyrica [2.8]
Celebrex [2.4]
2 [3]
Sanofi -Aventis
Paris, France [sanofi -aventis.com] $42.0 [8.5%] $6567
Lantus [4.4]
Lovenox [4.4]
Plavix [3.8]
3 [4]
Novartis
Basel, Switzerland [novartis.com] $38.4 [6.7%] $6308
Diovan/Co-Diovan [6.0]
Gleevec/Glivec [3.9]
Zometa [1.5]
4 [2]
GlaxoSmithKline
Brentford, England [gsk.com] $37.8 [26.1%] $6286
Seretide/Advair [7.9]
Valtrex [2.1]
Pandemic fl u vaccine [1.4]
5 [8]
Roche
Basel, Switzerland [roche.com] $37.6 [78.9%] $8570
Avastin [6.0]
MabThera/Rituxan [5.9]
Herceptin [5.1]
6 [6]
AstraZeneca
London, England [astrazeneca.com] $32.8 [3.8%] $4409
Nexium [5.0]
Seroquel [4.9]
Crestor [4.5]
7 [7]
Merck
Whitehouse Station, New Jersey
[merck.com]
$25.2 [6.9%] $5845
Singulair [4.7]
Corzaar/Hyzaar [3.6]
Januvia [1.9]
8 [6]
Johnson & Johnson
New Brunswick, New Jersey [jnj.com] $22.5 [-8.5%] $4591
Remicade [4.3]
Procrit/Eprex [2.2]
Levaquin/Floxin [1.6]
9 [9]
Eli Lilly
Indianapolis, Indiana [lilly.com] $21.2 [9.7%] $4300
Zyprexa [4.9]
Cymbalta [3.1]
Humalog [2.0]
10 [11]
Bristol-Myers Squibb
New York [bms.com] $18.8 [6.3%] $3647
Plavix [6.1]
Abilify [2.6]
Reyataz [1.4]
shortly coming with the entire list of Top 50.
